Small molecules and a pharmacophore model for inhibition of anthrax lethal factor
    3.
    发明申请
    Small molecules and a pharmacophore model for inhibition of anthrax lethal factor 失效
    小分子和抑制炭疽致死因子的药效团模型

    公开(公告)号:US20050251345A1

    公开(公告)日:2005-11-10

    申请号:US11017771

    申请日:2004-12-22

    摘要: Disclosed herein is a pharmacophore model for inhibiting anthrax lethal factor protease activity which comprises a first aromatic center A, a second aromatic center B, a first polar center C, a second polar center D, a third polar center E, and a neutral linker F. In some embodiments, the distance between the first aromatic center A and the neutral linker F is about 4.7 to about 6.7 Å, preferably about 5.7 Å. In some embodiments, the distance between the neutral linker F and the second aromatic center B is about 3.4 to about 4.4 Å, preferably about 3.9 Å. In some embodiments, the distance between first aromatic center A and the first polar center C is about 5.5 to about 7.5 Å, preferably about 6.5 Å. In some embodiments, the distance between the first aromatic center A and the second polar center D is about 4.6 to about 6.6 Å, preferably about 5.6 Å. In some embodiments, the distance between the second aromatic center B and the second polar center D is about 3.6 to about 4.6 Å, preferably about 4.1 Å. In some embodiments, the distance between the second aromatic center B and the third polar center E is about 2.6 to about 3.6 Å, preferably about 3.1 Å. In some embodiments, the distance between the first polar center C and the third polar center E is about 15.6 to about 19.6 Å, preferably about 17.6 Å. Also disclosed are small molecules fitting the pharmacophore model and compositions and methods of using thereof.

    摘要翻译: 本文公开了用于抑制炭疽致死因子蛋白酶活性的药效团模型,其包含第一芳族中心A,第二芳族中心B,第一极中心C,第二极中心D,第三极中心E和中性接头F 在一些实施方案中,第一芳族中心A和中性接头F之间的距离为约4.7至约6.7,优选约为5.7。 在一些实施方案中,中性接头F和第二芳族中心B之间的距离为约3.4至约4.4,优选约为3.9。 在一些实施方案中,第一芳族中心A和第一极性中心C之间的距离为约5.5至约7.5,优选约为6.5。 在一些实施方案中,第一芳族中心A和第二极性中心D之间的距离为约4.6至约6.6,优选约为。 在一些实施方案中,第二芳族中心B和第二极性中心D之间的距离为约3.6至约4.6,优选约为4.1。 在一些实施方案中,第二芳族中心B和第三极性中心E之间的距离为约2.6至约3.6,优选约为。 在一些实施方案中,第一极心C和第三极心E之间的距离为约15.6至约19.6,优选约17.6。 还公开了拟合药效团模型及其使用方法的小分子。

    Small molecules and a pharmacophore model for inhibition of botulinum toxin and methods of making and using thereof
    5.
    发明授权
    Small molecules and a pharmacophore model for inhibition of botulinum toxin and methods of making and using thereof 失效
    用于抑制肉毒杆菌毒素的小分子和药效团模型及其制备和使用方法

    公开(公告)号:US07574340B2

    公开(公告)日:2009-08-11

    申请号:US10935622

    申请日:2004-09-08

    IPC分类号: G06G7/48

    摘要: Disclosed herein is a pharmacophore model for inhibiting Botulinum neurotoxin A metalloprotease activity which comprises a first plane A, a second plane B, a first hydrophobic moiety C, a second hydrophobic moiety D and a positive ionizable substituent E. The pharmacophore model may further comprise a heteroatom in the first plane A. In some embodiments, the distance between the center of the first plane A and the center of the second plane B is about 6.5 to about 9.5 Å. In some embodiments, the distance between the center of the first hydrophobic moiety C and the center of the second hydrophobic moiety D is about 8.0 to about 16.0 Å. In some embodiments, the distance between the center of the first plane to the center of the first hydrophobic moiety C is about 3.0 to about 5.0 Å. In some embodiments, the distance between the center of the second plane to the center of the second hydrophobic moiety C is about 3.0 to about 5.0 Å. In some embodiments, the distance between the center of the first plane to the center of the positive ionizable substituent is about 6.5 to about 9.5 Å.

    摘要翻译: 本文公开了用于抑制肉毒杆菌神经毒素A金属蛋白酶活性的药效团模型,其包含第一平面A,第二平面B,第一疏水部分C,第二疏水部分D和可阳离子化取代基E.药效基团模型还可包含 在一些实施例中,第一平面A的中心与第二平面B的中心之间的距离为约6.5至约9.5。 在一些实施方案中,第一疏水部分C的中心与第二疏水部分D的中心之间的距离为约8.0至约16.0。 在一些实施方案中,第一平面的中心与第一疏水部分C的中心之间的距离为约3.0至约5.0。 在一些实施方案中,第二平面的中心与第二疏水部分C的中心之间的距离为约3.0至约5.0。 在一些实施方案中,第一平面的中心与正电离取代基的中心之间的距离为约6.5至约9.5。

    Small molecules and a pharmacophore model for inhibition of botulinum toxin and methods of making and using thereof
    9.
    发明申请
    Small molecules and a pharmacophore model for inhibition of botulinum toxin and methods of making and using thereof 失效
    用于抑制肉毒杆菌毒素的小分子和药效团模型及其制备和使用方法

    公开(公告)号:US20050153945A1

    公开(公告)日:2005-07-14

    申请号:US10935622

    申请日:2004-09-08

    摘要: Disclosed herein is a pharmacophore model for inhibiting Botulinum neurotoxin A metalloprotease activity which comprises a first plane A, a second plane B, a first hydrophobic moiety C, a second hydrophobic moiety D and a positive ionizable substituent E. The pharmacophore model may further comprise a heteroatom in the first plane A. In some embodiments, the distance between the center of the first plane A and the center of the second plane B is about 6.5 to about 9.5 Å. In some embodiments, the distance between the center of the first hydrophobic moiety C and the center of the second hydrophobic moiety D is about 8.0 to about 16.0 Å. In some embodiments, the distance between the center of the first plane to the center of the first hydrophobic moiety C is about 3.0 to about 5.0 Å. In some embodiments, the distance between the center of the second plane to the center of the second hydrophobic moiety C is about 3.0 to about 5.0 Å. In some embodiments, the distance between the center of the first plane to the center of the positive ionizable substituent is about 6.5 to about 9.5 Å.

    摘要翻译: 本文公开了用于抑制肉毒杆菌神经毒素A金属蛋白酶活性的药效团模型,其包含第一平面A,第二平面B,第一疏水部分C,第二疏水部分D和可阳离子化取代基E.药效基团模型还可包含 在一些实施例中,第一平面A的中心与第二平面B的中心之间的距离为约6.5至约9.5。 在一些实施方案中,第一疏水部分C的中心与第二疏水部分D的中心之间的距离为约8.0至约16.0。 在一些实施方案中,第一平面的中心与第一疏水部分C的中心之间的距离为约3.0至约5.0。 在一些实施方案中,第二平面的中心与第二疏水部分C的中心之间的距离为约3.0至约5.0。 在一些实施方案中,第一平面的中心与正电离取代基的中心之间的距离为约6.5至约9.5。